Randomised controlled trial examining the effect of decreased waiting time for the first doctors' appointment, patient education, glove counselling and counselling at departments of social or occupational medicine on severity of hand eczema, quality of life, use of corticosteroids, and jobsituation 3-12 months after intervention in patients with suspected occupational contact dermatitis of the hands.
Patients with suspected occupational hand eczema are recruited to the study on basis of their referral from general practitioner to dermatologist. Patients are randomised to either control or intervention group. The control group is treated and followed-up by the dermatologist they have been referred to, while the intervention group is treated and followed-up at Gentofte Hospital skin department with a maximum waiting time of 3 weeks. At the skin department at Gentofte Hospital, the patients in the intervention group receive patient education in prevention and treatment of hand eczema, glove counselling, personal product screening by a chemistry engineer, extended allergy testing and the standard treatment of hand eczema. Patients in both the control and intervention group are asked to fill out a questionnaire at 3, 6, 9 and 12 months after inclusion in the study. The questionnaire contains questions about quality of life, severity of hand exzema, jobsituation, use of healthcare service and use of medicine. Furthermore, prescriptions of medicine are registered in both control and intervention group at 3, 6, 9 and 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
50
Treatment in a hospital setting at Gentofte Hospital skin department
Gentofte Hospital, Skin department
Hellerup, Denmark
Change in severity of handeczema assessed by the hand eczema severity index (HECSI) 0-360 points (0 best, 360 worst)
The hand eczema severity index (HECSI)
Time frame: Change between baseline and 3 months
Change in severity of handeczema assessed by the photographic guide for severity of handeczema
Self-assessed photographic guide
Time frame: Change between baseline and 3 months
Change in severity of handeczema assessed by the photographic guide for severity of handeczema
Self-assessed photographic guide
Time frame: Change between baseline and 6 months
Change in severity of handeczema assessed by the photographic guide for severity of handeczema
Self-assessed photographic guide
Time frame: Change between baseline and 9 months
Change in severity of handeczema assessed by the photographic guide for severity of handeczema
Self-assessed photographic guide
Time frame: Change between baseline and 12 months
Change in severity of handeczema assessed by a visual analog score 0-100 (0 best, 100 worst)
Visual analog Score for severity of handeczema
Time frame: Change between baseline and 3 months
Change in severity of handeczema assessed by a visual analog score 0-100 (0 best, 100 worst)
Visual analog Score for severity of handeczema
Time frame: Change between baseline and 6 months
Change in severity of handeczema assessed by a visual analog score 0-100 (0 best, 100 worst)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Visual analog Score for severity of handeczema
Time frame: Change between baseline and 9 months
Change in severity of handeczema assessed by a visual analog score 0-100 (0 best, 100 worst)
Visual analog Score for severity of handeczema
Time frame: Change between baseline and 12 months
Amount of corticosteroids prescribed within the last year
Amount of corticosteroids prescribed wihtin the last year
Time frame: Baseline
Amount of corticosteroids prescribed within the last 3 months
Amount of corticosteroids prescribed within the last 3 months
Time frame: 3 months
Amount of corticosteroids prescribed within the last 3 months
Amount of corticosteroids prescribed within the last 3 months
Time frame: 6 months
Amount of corticosteroids prescribed within the last 3 months
Amount of corticosteroids prescribed within the last 3 months
Time frame: 9 months
Amount of corticosteroids prescribed within the last 3 months
Amount of corticosteroids prescribed within the last 3 months
Time frame: 12 months
Health-Related Quality of Life assessed by Skindex-29, scale ranging from 0-100 points (higher score = higher impact of skin disease on quality of life)
Skindex-29
Time frame: Baseline
Health-Related Quality of Life assessed by Skindex-29, scale ranging from 0-100 points (higher score = higher impact of skin disease on quality of life)
Skindex-29
Time frame: 3 months
Health-Related Quality of Life assessed by Skindex-29, scale ranging from 0-100 points (higher score = higher impact of skin disease on quality of life)
Skindex-29
Time frame: 6 months
Health-Related Quality of Life assessed by Skindex-29, scale ranging from 0-100 points (higher score = higher impact of skin disease on quality of life)
Skindex-29
Time frame: 9 months
Health-Related Quality of Life assessed by Skindex-29, scale ranging from 0-100 points (higher score = higher impact of skin disease on quality of life)
Skindex-29
Time frame: 12 months
Health-Related Quality of Life assessed by "European Quality of Life - 5 Dimensions" (EQ-5D)
"European Quality of Life - 5 Dimensions" (EQ-5D)
Time frame: Baseline
Health-Related Quality of Life assessed by "European Quality of Life - 5 Dimensions" (EQ-5D)
"European Quality of Life - 5 Dimensions" (EQ-5D)
Time frame: 3 months
Health-Related Quality of Life assessed by "European Quality of Life - 5 Dimensions" (EQ-5D)
"European Quality of Life - 5 Dimensions" (EQ-5D)
Time frame: 6 months
Health-Related Quality of Life assessed by "European Quality of Life - 5 Dimensions" (EQ-5D)
"European Quality of Life - 5 Dimensions" (EQ-5D)
Time frame: 9 months
Health-Related Quality of Life assessed by "European Quality of Life - 5 Dimensions" (EQ-5D)
"European Quality of Life - 5 Dimensions" (EQ-5D)
Time frame: 12 months
Health-Related Quality of Life assessed by Dermatology life quality index (DLQI) 0-30 (higher score = higher impact of skin disease on quality of life)
Dermatology life quality index (DLQI)
Time frame: Baseline
Health-Related Quality of Life assessed by Dermatology life quality index (DLQI) 0-30 (higher score = higher impact of skin disease on quality of life)
Dermatology life quality index (DLQI)
Time frame: 3 months
Health-Related Quality of Life assessed by Dermatology life quality index (DLQI) 0-30 (higher score = higher impact of skin disease on quality of life)
Dermatology life quality index (DLQI)
Time frame: 6 months
Health-Related Quality of Life assessed by Dermatology life quality index (DLQI) 0-30 (higher score = higher impact of skin disease on quality of life)
Dermatology life quality index (DLQI)
Time frame: 9 months
Health-Related Quality of Life assessed by Dermatology life quality index (DLQI) 0-30 (higher score = higher impact of skin disease on quality of life)
Dermatology life quality index (DLQI)
Time frame: 12 months
Number of participants with loss of job within the last year
Self-repported loss of job wihtin the last year
Time frame: Baseline
Number of participants with loss of job within the last 3 months
Self-repported loss of job within the last 3 months
Time frame: Baseline
Number of participants with loss of job within the last 3 months
Self-repported loss of job within the last 3 months
Time frame: 3 months
Number of participants with loss of job within the last 3 months
Self-repported loss of job within the last 3 months
Time frame: 6 months
Number of participants with loss of job within the last 3 months
Self-repported loss of job within the last 3 months
Time frame: 9 months
Number of participants with loss of job within the last 3 months
Self-repported loss of job within the last 3 months
Time frame: 12 months
Amount of sick leave within the last year
Self-repported amount of sick leave within the last year
Time frame: Baseline
Amount of sick leave within the last 3 months
Self-repported amount of sick leave within the last 3 months
Time frame: 3 months
Amount of sick leave within the last 3 months
Self-repported amount of sick leave within the last 3 months
Time frame: 6 months
Amount of sick leave within the last 3 months
Self-repported amount of sick leave within the last 3 months
Time frame: 9 months
Amount of sick leave within the last 3 months
Self-repported amount of sick leave within the last 3 months
Time frame: 12 months
Number of participants with change of occupation due to occupational contact dermatitis within the last year
Change of occupation due to occupational contact dermatitis within the last year
Time frame: Baseline
Number of participants with change of occupation due to occupational contact dermatitis within the last 3 months
Change of occupation due to occupational contact dermatitis within the last 3 months
Time frame: 3 months
Number of participants with change of occupation due to occupational contact dermatitis within the last 3 months
Change of occupation due to occupational contact dermatitis within the last 3 months
Time frame: 6 months
Number of participants with change of occupation due to occupational contact dermatitis within the last 3 months
Change of occupation due to occupational contact dermatitis within the last 3 months
Time frame: 9 months
Number of participants with change of occupation due to occupational contact dermatitis within the last 3 months
Change of occupation due to occupational contact dermatitis within the last 3 months
Time frame: 12 months